Analysis of pregnancy and childbirth in women with multiple sclerosis: a prospective study

Cover Page


Cite item

Abstract

Introduction. Family planning for patients with multiple sclerosis (MS) raises many questions and requires an integrated approach from neurologists and obstetrician-gynaecologists.

The study aimed to define possible features of pregnancy and childbirth in patients with MS.

Materials and methods. 204 patients with definite moderate MS, who were planning a pregnancy and taking First-Line Disease-Modifying Therapies (DMTs) before pregnancy. First group included 94 patients with pregnancies; the second group consisted of 110 patients, who failed to conceive within a stated period of time; in the third group there were 50 healthy women with normal pregnancies. Probability of developing pregnancy complications, time and method of delivery, anaesthetic procedures, weight, and height of newborns were assessed, while in the groups of patients with MS the risk of exacerbations and severity of the complications were evaluated.

Results and discussion. In the first group, there were more frequent threats of miscarriage and preterm birth, which might have taken place due to a complex of factors (cancellation of DMTs, use of hormonal therapy for exacerbations during pregnancy). The high frequency of caesarean section in the first group was associated with the unreasonable alertness of obstetrician-gynaecologists and the fear of the patients that the course of MS would worsen. Frequent exacerbations during pregnancy were associated with the abolition of DMTs before pregnancy and the failure of physiological immunosuppression during pregnancy.

Conclusion. In Russia, there is no single protocol for managing patients with MS during the period of family planning, pregnancy, and the postpartum period, which causes certain difficulties. There is emerging evidence that certain DMTs can be prescribed during pregnancy and lactation, which will help minimize the risks of exacerbations and disability increase.

About the authors

Andrey V. Murashko

I.M. Sechenov First Moscow State Medical University

Author for correspondence.
Email: ani_retake1@mail.ru
Russian Federation, Moscow

Aleksander I. Muravin

I.M. Sechenov First Moscow State Medical University

Email: ani_retake1@mail.ru
Russian Federation, Moscow

Ekaterina V. Popova

City Clinical Hospital No. 24; Pirogov Russian National Research Medical University

Email: ani_retake1@mail.ru
Russian Federation, Moscow

Sergey A. Ryabov

Pirogov Russian National Research Medical University

Email: ani_retake1@mail.ru
Russian Federation, Moscow

References

  1. Gusev E.I., Zavalishin I.A., Boyko A.N. [Multiple sclerosis: a clinical guide]. Moscow: Real Time, 2011. 520 p. (In Russ.)
  2. Gusev V.A., Kholopov B.K. [About the provoking effect of pregnancy, childbirth and the postpartum period on various forms of multiple sclerosis]. Sovetskaya meditsina 1978; (12): 31–33. (In Russ.)
  3. Popova E.V., Kukel T.M., Muravin A.I. et al. [Retrospective analysis of the course of pregnancy and childbirth in women with multiple sclerosis]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2013; 113(10): 52–56. (In Russ.)
  4. Borisow N., Friedemann P., Ohlraun S. et al. Pregnancy in multiple sclerosis: a questionnaire study. PLoS One 2014; 9: e99106. doi: 10.1371/journal.pone.0099106. PMID: 24901447.
  5. Coyle P.K. Multiple sclerosis in pregnancy. Continuum (Minneap Minn) 2014; 20: 42–59. doi: 10.1212/01.CON.0000443836.18131.c9. PMID: 24492810.
  6. Buraga I., Popovici R.E. Multiple sclerosis and pregnancy: current considerations. ScientificWorldJournal 2014; 2014: 513160. doi: 10.1155/2014/513160. PMID: 24977202.
  7. Polman C.H., Reingold S.C., Banwell B. et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69: 292–302. doi: 10.1002/ana.22366. PMID: 21387374.
  8. Freedman M.S., Rush C.A. Severe, Highly Active, or Aggressive Multiple Sclerosis. Continuum (Minneap Minn) 2016; 22: 761–784. doi: 10.1212/CON.0000000000000331. PMID: 27261681.
  9. Coyle P.K. Management of women with multiple sclerosis through pregnancy and after childbirth. Ther Adv Neurol Disord 2016; 9: 198–210. doi: 10.1177/1756285616631897. PMID: 27134675.
  10. Thiel S., Langer-Gould A., Rockhoff M. et al. Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and PregnancyRegistry. Mult Scler 2016; 22: 801–809. doi: 10.1177/1352458516634872. PMID: 26920382.
  11. Herbstritt S., Langer-Gould A., Rockhoff M. et al. Glatiramer acetate during early pregnancy: A prospective cohort study. Mult Scler 2016; 22: 810–816. doi: 10.1177/1352458515623366. PMID: 26754804.
  12. Pharmacovigilance Risk Assessment Committee, European Medicines Agency. Draft agenda for the meeting on 2–5 September 2019. URL: https://www.ema.europa.eu/en/documents/agenda/agenda-prac-draft-agenda-meeting-2-5-september-2019_en.pdf .

Copyright (c) 2019 Murashko A.V., Muravin A.I., Popova E.V., Ryabov S.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies